Clinical Trials Directory

Trials / Unknown

UnknownNCT05475860

Biomarkers Predicting Atrial High Rate Episodes in Cardiac Implantable Electronic Device Recipients

Predictors of Atrial High Rate Episodes in Patients Implanting Cardiac Implantable Electronic Device Based on Biomarkers

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Pusan National University Hospital · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

This study is sought to investigate any predictors including biomarkers for atrial high rate episodes (AHRE) occurrence in patients without prior history of atrial tachyarrhythmias receiving cardiac implantable electronic device (CIED).

Detailed description

Atrial high rate episodes (AHRE) are noticed up to 70% in patients receiving cardiac implantable electronic device (CIED) even in the absence of prior history of atrial tachyarrhythmias. AHRE is clinically important because it is considered to be associated with clinical atrial fibrillation, stroke, mortality, and heart failure hospitalization. Therefore, predictors of AHRE might be useful for early detection of AHRE susceptable CIED recipients. Biomarkers as well as clinical characteristics will be analyzed.

Conditions

Interventions

TypeNameDescription
DEVICEimplantable cardiac electronic device recipientsimplantable cardiac electronic device recipients for any clinical indication

Timeline

Start date
2022-07-24
Primary completion
2024-02-28
Completion
2024-07-31
First posted
2022-07-27
Last updated
2022-07-27

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05475860. Inclusion in this directory is not an endorsement.